Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization (Q38092061)

28 August 2017

title

Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization (English)

1 reference

28 August 2017

Kun Zhang

1 reference

28 August 2017

Tao Liu

1 reference

28 August 2017

Jing-An Li

1 reference

28 August 2017

Jun-Ying Chen

1 reference

28 August 2017

Jian Wang

1 reference

28 August 2017

Nan Huang

1 reference

28 August 2017

publication date

24 August 2013

1 reference

Journal of Biomedical Materials Research Part A

28 August 2017

published in

1 reference

28 August 2017

volume

102

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

588-609

1 reference

Sun, vitamin D, and cardiovascular disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Challenges and opportunities for cardiovascular disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Adaptive immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Coronary stents: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Stent thrombosis is not always stent thrombosis: de novo atherosclerosis in a stented coronary segment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

In-stent restenosis and thrombosis 41 months after drug-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A case of very late stent thrombosis after bare metal coronary stent implantation: a neglected complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

An angiographic evaluation of restenosis rate at a six-month follow-up of patients with ST-elevation myocardial infarction submitted to primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Molecular basis of restenosis and drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Coronary in-stent restenosis: current status and future strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Prosthetic vascular graft infection: a risk factor analysis using a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Bare metal stent infections: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Basilar artery dissection treated by Neuroform stenting: fungal stent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Left main stem rupture caused by methicillin resistant Staphylococcus aureus infection of left main stent treated by covered stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Prevention of early vascular graft infection using regional antibiotic release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Fighting bacterial infections—Future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Coronary stents: looking forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The use of layer by layer self-assembled coatings of hyaluronic acid and cationized gelatin to improve the biocompatibility of poly(ethylene terephthalate) artificial ligaments for reconstruction of the anterior cruciate ligament.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Initial exploration of Ti-Ta, Ti-Ta-Ir and Ti-Ir alloys: Candidate materials for coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Polymeric coating of surface modified nitinol stent with POSS-nanocomposite polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Bioengineered surfaces to improve the blood compatibility of biomaterials through direct thrombin inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Cardiac surgery in patients on antiplatelet and antithrombotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Dissecting the role of mTOR: lessons from mTOR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent f

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Late occlusive in-stent restenosis of a bare-metal stent presenting with ST-elevation anterior MI: is restenosis better than a late stent thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Very late stent fracture associated with a sirolimus-eluting stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Late restenosis following sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Drug-eluting stent safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Drug-eluting stents: issues of late stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Interaction of endothelial cells with self-assembled monolayers for potential use in drug-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

HEPARIN BONDING ON COLLOIDAL GRAPHITE SURFACES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The anti-inflammatory effects of heparin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Platelet activation after stenting with heparin-coated versus noncoated stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An ex-vivo canine shunt study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Improved blood compatibility of a stent graft by combining heparin coating and abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Simple surface modification of a titanium alloy with silanated zwitterionic phosphorylcholine or sulfobetaine modifiers to reduce thrombogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Novel constructs for thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The creation of an antithrombotic surface by apyrase immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The glycation of albumin: structural and functional impacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Novel thromboresistant materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Late lumen loss and follow-up percent diameter stenosis at different doses of oral valsartan six months after bare-metal stent implantation in type B2/C coronary lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

New drug-eluting stent concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The forgotten player of in-stent restenosis: endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

In vitro and in vivo performance of a dual drug-eluting stent (DDES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Early restenosis after drug-eluting stent implantation: A putative role for platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Drug-eluting stents and other anti-restenosis devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The influence of physical stent parameters upon restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Investigation of surface endothelialization on biomedical nitinol (NiTi) alloy: Effects of surface micropatterning combined with plasma nanocoatings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Radionuclides-hyaluronan-conjugate thromboresistant coatings to prevent in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Dexamethasone loaded bioresorbable films used in medical support devices: structure, degradation, crystallinity and drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Inhibition of phosphodiesterase has an additive effect on estrogen's ability to inhibit collagen synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

An effective vascular-healing agent after coronary stent implantation: estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Adult 'endothelial progenitor cells'. Renewing vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Induced Pluripotent Stem Cells-A New Foundation in Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

How far are induced pluripotent stem cells from the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Potential of endogenous regenerative technology for in situ regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cells in vascular repair and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Seeding of intracoronary stents with immortalized human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The influence of biomaterials on endothelial cell thrombogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Pathogenesis of atherosclerosis: a possible relation to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cells in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Vascular wall resident progenitor cells: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A new source of endothelial progenitor cells--vascular biology redefined?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cell-based neovascularization: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cells--an evolving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cells and cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Influence of surface topography on endothelialization of intravascular metallic material

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Topographic guidance of endothelial cells on silicone surfaces with micro- to nanogrooves: orientation of actin filaments and focal adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Modulation of human vascular endothelial cell behaviors by nanotopographic cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Microtopography and flow modulate the direction of endothelial cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

UV-O3-treated and protein-coated polymer surfaces facilitate endothelial cell adhesion and proliferation mediated by the PKCalpha/ERK/cPLA2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Modulation of endothelial nitric oxide by plant-derived products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The extracellular matrix as a biologic scaffold material.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Electrospun collagen-chitosan nanofiber: a biomimetic extracellular matrix for endothelial cell and smooth muscle cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The linker-free covalent attachment of collagen to plasma immersion ion implantation treated polytetrafluoroethylene and subsequent cell-binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Linker-free covalent attachment of the extracellular matrix protein tropoelastin to a polymer surface for directed cell spreading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Understanding the role of endothelial progenitor cells in percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cell capture stents--hype or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Adaptive recognition by nucleic acid aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34714

21 January 2018

Identifiers

DOI

10.1002/JBM.A.34714

1 reference

28 August 2017

1 reference